Hit-and-run programming of therapeutic cytoreagents using mRNA nanocarriers

Area of Science:

• Cellular reprogramming
• Nanotechnology
• Immunotherapy

Background:

• Current methods for creating therapeutic cells, such as viral and electroporation techniques, are complex and expensive.
• There is a need for simpler and more scalable methods to engineer cells for therapeutic applications.

Purpose of the Study:

• To develop and demonstrate a novel method for transiently programming cells using targeted messenger RNA (mRNA) nanocarriers.
• To establish the simplicity and generalizability of this mRNA nanocarrier approach for various cell types and therapeutic goals.

Main Methods:

• Development of targeted mRNA nanocarriers designed for simple mixing with cells.
• Delivery of mRNA encoding specific proteins (e.g., genome-editing agents, transcription factors) into cells.
• Application of the method to T-cells and hematopoietic stem cells.

Main Results:

• Demonstrated efficient gene knock-out in anti-cancer T-cells using mRNA nanocarriers encoding genome-editing agents.
• Successfully imparted a long-lived phenotype with enhanced antitumor activity into T-cells by delivering mRNA for a memory formation transcription factor.
• Showcased improved self-renewal properties in hematopoietic stem cells programmed with mRNA nanocarriers.

Conclusions:

• The developed mRNA nanocarrier system provides a simple, generalizable, and efficient method for transiently programming cells.
• This approach offers a significant advantage over current complex protocols, potentially facilitating the manufacturing of therapeutic cytoreagents.
• The technology holds promise for advancing cell-based therapies for a range of diseases.